Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Botanical Drug Association is a U.S.-based nonprofit organization focused on advancing FDA-regulated prescription botanical drugs and modern herbal medicines. The organization supports botanical drug research and development through regulatory and development services such as IND preclinical testing, IND/NDA submission support, and quality-control method development. It also publishes the open-access Botanical Drugs journal and maintains access to a large repository of botanical reference standards generated through HPLC-based analytical work. Rather than operating as a traditional therapeutics developer with a disclosed internal clinical pipeline, ABDA appears to function primarily as an industry association and service platform supporting sponsors, researchers, and manufacturers in botanical drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Botanical Drug Association.